2025-08-11 OPEN Foundation

First Patient Included Marks Major Milestone in EU-Funded Clinical Trial

Amsterdam, Netherlands, August 11, 2025 — PsyPal has reached a major milestone with the inclusion of its first patient in the multi-site clinical trial investigating psilocybin therapy for psychological and existential distress in people with progressive, life-limiting illnesses. The first patient has been included at University Medical Center Groningen (UMCG), Netherlands, one of four specialised […] The post First Patient Included Marks Major Milestone in EU-Funded Clinical Trial appeared first on OPEN Foundation.

External link. We are not responsible for the content.

Read more ↗

More From OPEN Foundation

2026-02-27 OPEN Foundation

Ketamine-Assisted Psychotherapy for Mental Disorders: What Does the Evidence Actually Show?

A new systematic review in Clinical Psychology Review offers the most comprehensive overview to date of studies combi...

2026-01-27 OPEN Foundation

The Perils of Non-Hallucinogenic Claims: On the Limits of Translatability

This is Part II of a double feature discussing the current stage in research and development of the different classes...

2025-12-09 OPEN Foundation

DMT and the Brain: A New Doorway Into Brain Renewal

In the past years, psychedelic science has focused heavily on how substances like psilocybin, LSD, and ayahuasca affe...

Latest News

2026-02-28 Chemical Collective

Comment perfectionner la préparation de son trip ?

La préparation d’un voyage est un processus à la fois intérieur et extérieur – qui consiste à aligner l’intention, l’...

2026-02-27 Lucid News

Authors of Largest Microdosing Study Suggest Benefits Limited To Dosing Day

Recent research surveying 1,435 microdosers suggests that microdosing’s duration of effect might be more like that of...

Microdosing Research
2026-02-27 The Microdose (Berkeley)

The FDA is changing the drug approval process; In a Senate hearing, Surgeon General nominee Casey Means was asked about psychedelics use

Plus: RAND survey shows that nearly a quarter of U.S. adults support legal use of psilocybin mushrooms; Reunion Neuro...

2026-02-27 Psychedelic Alpha

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

In this conversation with Psychedelic Alpha’s Josh Hardman, Dr. Terence Ching discusses his journey into the field an...

2026-02-27 Tripsitter (Substack)

Can Psychedelics Break the Consumption Cycle?

Consumer culture doesn’t just shape what we buy — it shapes what we want. Here’s why that’s harder to escape than you...

2026-02-27 The Psychedelic Blog (Substack)

Psychedelics Can Just Be for Fun

Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.